Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. (Q48658753)

14 February 2018

title

Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. (English)

1 reference

14 February 2018

0 references

1 reference

Lena Lavie

1

1 reference

14 February 2018

Holger Kraiczi

2

1 reference

14 February 2018

Aya Hefetz

3

1 reference

14 February 2018

Haifa Ghandour

4

1 reference

14 February 2018

Ana Perelman

5

1 reference

14 February 2018

Jan Hedner

6

1 reference

14 February 2018

Peretz Lavie

7

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 June 2002

1 reference

14 February 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

14 February 2018

volume

165

1 reference

14 February 2018

issue

12

1 reference

14 February 2018

page(s)

1624-1628

1 reference

14 February 2018

The occurrence of sleep-disordered breathing among middle-aged adults

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Impairment of vascular endothelial function and left ventricular filling : association with the severity of apnea-induced hypoxemia during sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Sleep apnea and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Sleep-disordered breathing, control of breathing, respiratory muscles, pulmonary function testing, nitric oxide, and bronchoscopy in AJRCCM 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Growth regulation of the vascular system: evidence for a metabolic hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea--hypopnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Antihypertensive pharmacogenetics: getting the right drug into the right patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Blood levels of vascular endothelial growth factor in obstructive sleep apnea-hypopnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Vascular endothelial growth factor suppresses C-type natriuretic peptide secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Circulating levels of interleukin-8 and vascular endothelial growth factor in patients with carotid stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Association of hypertension and sleep-disordered breathing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

Elevation of Vascular Endothelial Growth Factor-A Serum Levels Following Acute Myocardial Infarction. Evidence for its Origin and Functional Significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.20110-040OC

21 January 2018

Identifiers

DOI

10.1164/RCCM.20110-040OC

1 reference

14 February 2018

PubMed ID

12070063

1 reference

14 February 2018